The recombinant therapeutic antibodies and proteins industry has witnessed substantial advancements, driven by innovative biotechnologies and escalating demand across various therapeutic areas. With evolving treatment paradigms and expanding applications in oncology, autoimmune diseases, and rare disorders, this market reflects robust momentum shaped by strategic investments and evolv... https://hallbook.com.br/blogs/802113/Recombinant-Therapeutic-Antibodies-And-Proteins-Market-Growth-Driven-by-Innovation